Filter by: patients
What is Venlafaxine?

Venlafaxine is an antidepressant in a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). It affects chemicals in the brain that may become unbalanced and cause depression. It is used to treat major depressive disorder, anxiety, and panic disorder.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Depressed mood 790 256 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Major Depressive Disorder 602 146 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Generalized Anxiety Disorder 299 54 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Treat my mood condition(s) 232 83 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Anxious mood 192 79 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Fibromyalgia 141 49 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell

See all 1731 patients currently taking Venlafaxine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
126
Moderate
167
Mild
175
None
180

Commonly reported side effects, conditions, and hospitalizations associated with Venlafaxine

Weight gain 76
Brain zaps 48
Drowsiness 35
Agitation with restlessness 35
Nausea 32
Jittery feeling 29
See all 277 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Venlafaxine. See all 58 dosages

  37.5 mg daily 50 mg daily 75 mg daily 100 mg daily 112.5 mg daily 150 mg daily 225 mg daily 300 mg daily 375 mg daily 450 mg daily
  155 Number of Patients: 155 19 Number of Patients: 19 418 Number of Patients: 418 29 Number of Patients: 29 25 Number of Patients: 25 586 Number of Patients: 586 225 Number of Patients: 225 262 Number of Patients: 262 20 Number of Patients: 20 22 Number of Patients: 22  

Reported Stop Reasons

Why Patients Stopped Taking Venlafaxine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 256   Side effects too severe: 37%
Did not seem to work 249   Did not seem to work: 36%
Doctor's advice 180   Doctor's advice: 26%
Other 127   Other: 18%
Expense 65   Expense: 9%
Personal research 39   Personal research: 6%
Course of treatment ended 33   Course of treatment ended: 5%
Change in health plan coverage 18   Change in health plan coverage: 3%
Not indicated 9   Not indicated: 1%

See all 665 patients who’ve stopped taking Venlafaxine

Currently Taking Venlafaxine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Venlafaxine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Venlafaxine

Always
524 81%
Usually
98 15%
Sometimes
14 2%
Never
12 2%

Burden

Difficulty being on treatment

Burden of Venlafaxine

Very
43 7%
Somewhat
71 11%
A little
112 17%
Not at all
422 65%

Cost

Paid out of pocket

Cost of Venlafaxine

$200+
4 1%
$100-199
25 6%
$50-99
34 8%
$25-49
116 27%
< $25
242 57%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 25, 2012.